Medical Economics November 28, 2024
Key Takeaways
- GLP-1 receptor agonists are effective for obesity treatment but are associated with high costs, impacting patient access.
- Physicians should engage in transparent discussions with patients about the financial implications of GLP-1 RAs.
- Dr. Robert Kushner highlights the importance of balancing treatment efficacy with affordability and accessibility for patients.
- Experience in research and clinical practice informs strategies for addressing financial barriers in obesity treatment.
A physician researcher and author discusses the latest information...
Today's Sponsors
Today's Sponsor